2025 · 1st Quarter (Jan 1 - Mar 31)

HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION

Filed by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C..

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 17, 2025
Income: $50,000.00
Expenses: Not reported
Registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Client: HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION
Filing UUID: 0d8e592e-e0c2-4930-9d28-efaf6044b415
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY25 and FY26 Labor HHS and Related Agencies

HCR · Health Issues

The Cancer Drug Parity Act

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.